Chemicals · Founded 1975 · www.chembond.in · BSE 530871 · NSE CHEMBOND · ISIN INE995D01025
No Notes Added Yet
Business
Chembond Material Technologies Ltd. is an Indian specialty chemicals company involved in the development, manufacturing, and marketing of a diverse range of chemical products and solutions. The company serves various industrial and institutional clients. Its core business model revolves around providing value-added chemical solutions for applications such as water treatment, construction, industrial performance, and animal health & nutrition. Chembond makes money by selling these specialized products and offering related technical services to industries like power, automotive, infrastructure, manufacturing, and agriculture.
Revenue Mix
Chembond operates primarily across four main segments:
Water Treatment Chemicals: Provides solutions for cooling water, boiler water, wastewater treatment, and effluent treatment in various industrial settings.
Construction Chemicals: Offers products like concrete admixtures, waterproofing systems, industrial flooring, repair mortars, and grouts for the construction and infrastructure sectors.
Performance Chemicals: This segment often includes adhesives, coatings, sealants, and other specialty chemicals for automotive, general industrial, and engineering applications.
Animal Health & Nutrition: Manufactures and markets feed supplements, probiotics, toxin binders, and other nutritional products for poultry, dairy, aqua, and other livestock.
Detailed revenue contribution by segment is not readily available without access to recent financial reports or investor presentations.
Industry
The Indian chemicals industry is highly diverse and growing, with the specialty chemicals segment being a key driver. This segment is characterized by innovation, technical expertise, and customized solutions, serving a wide array of end-user industries. Chembond is positioned as a niche player within the broader specialty chemicals market. Rather than competing in commodity chemicals, it focuses on specific application areas where technical service and customized formulations are critical. It competes with both domestic and international players in its chosen segments, differentiating through product performance, technical support, and long-standing customer relationships.
MOAT
Chembond does not possess a wide, deep moat like a global brand, vast network effect, or extremely high switching costs typical of some other industries. However, it exhibits several competitive advantages that provide some durability:
Technical Expertise & R&D: Critical in specialty chemicals, allowing for product customization, problem-solving, and developing application-specific solutions.
Customer Relationships & Technical Service: Long-term relationships with industrial clients, built on consistent product quality and reliable technical support, can create stickiness and moderate switching costs.
Diversified Portfolio: Presence across multiple specialty chemical segments and end-user industries reduces reliance on any single market, offering resilience against sector-specific downturns.
Manufacturing and Distribution Footprint: An established network across India to serve diverse industrial customers.
Growth Drivers
Industrial Growth in India: Expansion in manufacturing, automotive, textiles, power, and other industrial sectors directly drives demand for specialty chemicals.
Infrastructure Development: Government spending and private investment in construction projects (roads, housing, ports) will fuel demand for construction chemicals.
Water Scarcity & Environmental Regulations: Increasing industrialization and urbanization necessitate more efficient water treatment and wastewater management solutions.
Growth in Animal Husbandry: Rising demand for protein, coupled with increasing awareness of animal health and nutrition, boosts the animal health segment.
New Product Development & Market Expansion: Continuous R&D and introduction of innovative products, along with exploring new geographical markets or application areas.
Risks
Raw Material Price Volatility: Many specialty chemicals are derived from crude oil or other commodity chemicals, making profit margins susceptible to fluctuations in raw material prices.
Intense Competition: The specialty chemicals market in India is competitive, with both large global players and numerous domestic manufacturers, potentially leading to pricing pressures and impacting margins.
Economic Slowdown: A slowdown in India's industrial output or construction activity would directly reduce demand for Chembond's products across its key segments.
Regulatory Changes: Evolving environmental, health, and safety regulations for chemical manufacturing and usage can lead to increased compliance costs or product reformulation requirements.
Technological Obsolescence: Failure to continuously innovate and adapt to new technologies or customer demands could result in loss of market share.
Management & Ownership
Chembond Material Technologies Ltd. is promoted by the Kothari family, with Mr. Nirmal V. Kothari serving as the Chairman & Managing Director. Promoter holding typically constitutes a significant portion of the ownership in such Indian companies, indicating strong alignment with the company's long-term interests. The remaining ownership is held by institutional investors, high-net-worth individuals, and the public. The management has experience in the specialty chemicals sector, guiding the company through its growth phases.
Outlook
Chembond Material Technologies Ltd. is well-positioned to capitalize on India's long-term industrialization and infrastructure growth story. Its diversified product portfolio across crucial sectors like water treatment, construction, and animal health provides a degree of resilience against cyclical downturns in any single segment. The company's focus on technical expertise and customized solutions for industrial clients should help it maintain its competitive standing.
However, the company operates in a highly competitive environment where raw material price volatility can impact profitability. Continuous investment in R&D and efficient operations will be crucial to counter competitive pressures and sustain growth. While benefiting from macro tailwinds, Chembond needs to navigate these operational and market challenges effectively to ensure consistent performance.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 47 | 46 | 50 | 53 | 52 | 58 | 58 | 63 | 72 | 72 |
| Other Income | 1 | 2 | 4 | 0 | 2 | 3 | 0 | 2 | -2 | 4 |
| Total Income | 48 | 48 | 53 | 53 | 54 | 60 | 58 | 64 | 70 | 76 |
| Total Expenditure | 44 | 43 | 47 | 49 | 49 | 54 | 54 | 59 | 65 | 69 |
| Operating Profit | 4 | 6 | 6 | 4 | 5 | 6 | 4 | 6 | 5 | 7 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Exceptional Income / Expenses | 0 | 0 | 2 | 0 | 0 | 0 | 0 | -2 | 0 | 0 |
| Profit Before Tax | 3 | 5 | 7 | 3 | 4 | 5 | 3 | 3 | 4 | 6 |
| Provision for Tax | 1 | 0 | 1 | -0 | 1 | 1 | -1 | 1 | 1 | 0 |
| Profit After Tax | 2 | 5 | 6 | 3 | 3 | 4 | 4 | 2 | 3 | 6 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
| Profit After Adjustments | 2 | 5 | 6 | 3 | 3 | 4 | 4 | 2 | 3 | 6 |
| Adjusted Earnings Per Share | 1.1 | 3.5 | 4.7 | 2.4 | 2.5 | 3 | 2.8 | 1.2 | 2.6 | 4.3 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 271 | 291 | 327 | 301 | 268 | 274 | 349 | 440 | 178 | 201 | 250 | 265 |
| Other Income | 33 | 18 | 11 | 4 | 3 | 15 | 9 | 5 | 14 | 8 | 6 | 4 |
| Total Income | 305 | 309 | 338 | 306 | 271 | 290 | 357 | 445 | 192 | 209 | 256 | 268 |
| Total Expenditure | 260 | 274 | 305 | 276 | 258 | 256 | 332 | 405 | 172 | 188 | 236 | 247 |
| Operating Profit | 44 | 35 | 33 | 29 | 13 | 34 | 26 | 39 | 20 | 21 | 21 | 22 |
| Interest | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 5 | 3 | 3 | 4 | 4 |
| Exceptional Income / Expenses | 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | -1 | -2 |
| Profit Before Tax | 195 | 30 | 28 | 24 | 8 | 29 | 21 | 34 | 17 | 19 | 16 | 16 |
| Provision for Tax | 38 | 7 | 4 | 5 | 5 | 8 | 7 | 9 | 6 | 2 | 3 | 1 |
| Profit After Tax | 156 | 23 | 24 | 20 | 3 | 20 | 14 | 25 | 11 | 18 | 13 | 15 |
| Adjustments | -3 | -4 | -2 | -3 | -1 | -0 | -0 | -0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 154 | 19 | 22 | 17 | 2 | 20 | 14 | 25 | 11 | 18 | 13 | 15 |
| Adjusted Earnings Per Share | 114.7 | 14.4 | 16.3 | 12.9 | 1.4 | 15.1 | 10.4 | 18.7 | 8.3 | 13.1 | 9.6 | 10.9 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 24% | -17% | -2% | -1% |
| Operating Profit CAGR | 0% | -19% | -9% | -7% |
| PAT CAGR | -28% | -20% | -8% | -22% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 10% | -19% | -4% | -2% |
| ROE Average | 8% | 8% | 7% | 16% |
| ROCE Average | 10% | 10% | 10% | 19% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 206 | 230 | 248 | 261 | 269 | 293 | 304 | 322 | 143 | 156 | 167 |
| Minority's Interest | 14 | 17 | 2 | 4 | 5 | 1 | 1 | 1 | 0 | 0 | 0 |
| Borrowings | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 3 | 6 | 3 | -0 | -0 | -1 | -1 | -2 | -2 | -3 | -3 |
| Total Current Liabilities | 64 | 67 | 72 | 55 | 46 | 58 | 54 | 77 | 48 | 46 | 51 |
| Total Liabilities | 289 | 321 | 325 | 321 | 321 | 352 | 359 | 398 | 190 | 199 | 215 |
| Fixed Assets | 47 | 49 | 108 | 109 | 124 | 122 | 121 | 116 | 26 | 34 | 41 |
| Other Non-Current Assets | 71 | 76 | 64 | 42 | 34 | 47 | 45 | 62 | 61 | 64 | 53 |
| Total Current Assets | 170 | 196 | 153 | 169 | 162 | 183 | 194 | 219 | 102 | 101 | 122 |
| Total Assets | 289 | 321 | 325 | 321 | 321 | 352 | 359 | 398 | 190 | 199 | 215 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 16 | 13 | 14 | 18 | 13 | 14 | 25 | 9 | 9 | 4 | 6 |
| Cash Flow from Operating Activities | -27 | 5 | -12 | -12 | 24 | 25 | -10 | 1 | 94 | 19 | 15 |
| Cash Flow from Investing Activities | 52 | -0 | 19 | 14 | -12 | -11 | -2 | 1 | -89 | -8 | -10 |
| Cash Flow from Financing Activities | -24 | -3 | -4 | -6 | -11 | -2 | -4 | -2 | -5 | -9 | -1 |
| Net Cash Inflow / Outflow | 1 | 2 | 3 | -5 | 1 | 12 | -16 | 0 | 0 | 2 | 3 |
| Closing Cash & Cash Equivalent | 17 | 14 | 18 | 13 | 14 | 25 | 9 | 9 | 4 | 6 | 9 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 114.72 | 14.37 | 16.34 | 12.88 | 1.39 | 15.13 | 10.35 | 18.66 | 8.31 | 13.06 | 9.59 |
| CEPS(Rs) | 119.47 | 19.83 | 20.58 | 17.9 | 5.53 | 18.56 | 13.73 | 22.06 | 10.49 | 15.03 | 12.22 |
| DPS(Rs) | 4.5 | 1.65 | 1.85 | 2 | 2 | 2.25 | 5 | 3 | 3.5 | 1.75 | 2 |
| Book NAV/Share(Rs) | 154 | 171.09 | 184.67 | 194.41 | 199.79 | 218.02 | 226.02 | 239.21 | 106.51 | 116.12 | 124.13 |
| Core EBITDA Margin(%) | 3.58 | 5.27 | 6.75 | 8.28 | 3.73 | 6.62 | 4.9 | 7.91 | 3.55 | 6.65 | 5.79 |
| EBIT Margin(%) | 63.88 | 9.78 | 8.7 | 8.36 | 3.24 | 10.55 | 6.08 | 7.94 | 9.79 | 9.98 | 6.35 |
| Pre Tax Margin(%) | 63.29 | 9.42 | 8.35 | 8.1 | 2.94 | 10.4 | 5.89 | 7.71 | 9.37 | 9.67 | 6.2 |
| PAT Margin (%) | 50.83 | 7.12 | 7.05 | 6.58 | 1.15 | 7.44 | 4.01 | 5.71 | 6.27 | 8.72 | 5.15 |
| Cash Profit Margin (%) | 51.98 | 8.31 | 8.28 | 7.99 | 2.77 | 9.1 | 5.29 | 6.74 | 7.92 | 10.04 | 6.57 |
| ROA(%) | 63.62 | 7.5 | 7.3 | 6.14 | 0.96 | 6.07 | 3.94 | 6.65 | 3.8 | 9.05 | 6.23 |
| ROE(%) | 103.85 | 10.48 | 9.85 | 7.78 | 1.16 | 7.26 | 4.68 | 8.04 | 4.81 | 11.73 | 7.98 |
| ROCE(%) | 116.49 | 13.76 | 11.72 | 9.58 | 3.21 | 10.21 | 7.07 | 11.04 | 7.3 | 13.02 | 9.63 |
| Receivable days | 85.2 | 71.05 | 80.82 | 103.93 | 117.94 | 110.35 | 90.56 | 84.87 | 167.8 | 80.34 | 67.75 |
| Inventory Days | 31.63 | 28.94 | 28.7 | 29.83 | 35.43 | 37.68 | 33.08 | 28.23 | 51.02 | 28.87 | 26.29 |
| Payable days | 99.94 | 92.12 | 90.42 | 101.59 | 98.67 | 107.38 | 79.96 | 70.68 | 157.22 | 111.66 | 92.04 |
| PER(x) | 1.82 | 12.78 | 18.76 | 24.82 | 105.8 | 12.55 | 17.29 | 13.57 | 57.65 | 38.69 | 11.11 |
| Price/Book(x) | 1.35 | 1.07 | 1.66 | 1.64 | 0.74 | 0.87 | 0.79 | 1.06 | 4.5 | 4.35 | 0.86 |
| Dividend Yield(%) | 2.16 | 0.9 | 0.6 | 0.63 | 1.36 | 1.18 | 2.79 | 1.18 | 0.73 | 0.35 | 1.88 |
| EV/Net Sales(x) | 1.01 | 0.83 | 1.23 | 1.41 | 0.7 | 0.84 | 0.64 | 0.72 | 3.58 | 3.32 | 0.52 |
| EV/Core EBITDA(x) | 6.15 | 6.86 | 12.17 | 14.4 | 14.44 | 6.92 | 8.67 | 8.02 | 31.28 | 31.54 | 6.26 |
| Net Sales Growth(%) | -9.72 | 7.28 | 12.61 | -7.99 | -11.04 | 2.39 | 27.12 | 26.14 | -59.5 | 12.93 | 24.23 |
| EBIT Growth(%) | 730.12 | -84.04 | -7.32 | -13.4 | -65.56 | 233.73 | -26.68 | 64.78 | -50.1 | 15.15 | -20.99 |
| PAT Growth(%) | 997.38 | -85.39 | 3.11 | -15.83 | -84.45 | 561.55 | -31.47 | 79.91 | -55.58 | 57.14 | -26.6 |
| EPS Growth(%) | 1134.51 | -87.47 | 13.67 | -21.16 | -89.19 | 986.25 | -31.57 | 80.28 | -55.47 | 57.14 | -26.6 |
| Debt/Equity(x) | 0.05 | 0.04 | 0.04 | 0.03 | 0.01 | 0.01 | 0.01 | 0.02 | 0.05 | 0.02 | 0.02 |
| Current Ratio(x) | 2.65 | 2.94 | 2.13 | 3.08 | 3.5 | 3.17 | 3.59 | 2.85 | 2.13 | 2.23 | 2.37 |
| Quick Ratio(x) | 2.3 | 2.52 | 1.79 | 2.63 | 2.91 | 2.66 | 2.96 | 2.41 | 1.81 | 1.87 | 1.98 |
| Interest Cover(x) | 108.43 | 26.9 | 24.6 | 32.21 | 11.08 | 68.62 | 30.8 | 33.59 | 22.96 | 31.51 | 43.28 |
| Total Debt/Mcap(x) | 0.04 | 0.04 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 | 0 | 0.03 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 67.56 | 67.61 | 67.63 | 67.65 | 67.65 | 67.65 | 67.72 | 68.08 | 68.11 | 68.22 |
| FII | 0.66 | 0.69 | 0.81 | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 |
| DII | 1.21 | 1.19 | 1.26 | 1.31 | 1.13 | 0.73 | 0.73 | 0.73 | 1.61 | 1.61 |
| Public | 30.57 | 30.51 | 30.3 | 30.42 | 30.61 | 31 | 30.93 | 30.58 | 29.67 | 29.56 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.92 | 0.92 | 0.92 |
| FII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| DII | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 |
| Public | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.42 | 0.42 | 0.41 | 0.4 | 0.4 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +24% | -17% | -2% | -1% |
| Operating Profit CAGR | 0% | -19% | -9% | -7% |
| PAT CAGR | -28% | -20% | -8% | -22% |
| Share Price CAGR | +10% | -19% | -4% | -2% |
| ROE Average | +8% | +8% | +7% | +16% |
| ROCE Average | +10% | +10% | +10% | +19% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 67.56 | 67.61 | 67.63 | 67.65 | 67.65 | 67.65 | 67.72 | 68.08 | 68.11 | 68.22 |
| FII | 0.66 | 0.69 | 0.81 | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 |
| DII | 1.21 | 1.19 | 1.26 | 1.31 | 1.13 | 0.73 | 0.73 | 0.73 | 1.61 | 1.61 |
| Public | 30.57 | 30.51 | 30.3 | 30.42 | 30.61 | 31 | 30.93 | 30.58 | 29.67 | 29.56 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.92 | 0.92 | 0.92 |
| FII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| DII | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 |
| Public | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.42 | 0.42 | 0.41 | 0.4 | 0.4 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.